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Abstract:  Mycobacteria are aerobic, nonspore forming, non-motile,single-cell bacteria.Of more than 40 currently   
recognized species of mycobacteria, Mycobacterium tuberculosis, the causative agent of human TB is the commonest 
pathogen for pulmonary and extra pulmonary tuberculosis cases. The other members of the Mycobacterium tuberculosis 
complex (MTC) or the nontubercular mycobacterium (NTM) produces similar diseases which cannot be differentiated 
from tuberculosis by clinical symptoms and signs. But this differentiation is important as the chemotherapy varies   
widely according to the strain of mycobacterium. The burden of morbidity and mortality of tuberculosis is rapidly   
growing worldwide, particularly with the HIV/AIDS epidemic. The strain identification of Mycobacterium remains a 
cumbersome, labor intensive and expensive procedure, which requires 3 to 12 weeks of time. The conventional methods of 
strain identification lack proper standardization and precise diagnosis. The prime objective of this study is to overcome 
these problems. 
A multiplex PCR using 3 amplicons of 165,365, and 541 base pair target sequences was done with a total number of  
165 clinical isolates of suspected Koch’s patients. Strain identification was compared both by conventional methods  
and multiplex PCR. The results of the study show that this multiplex PCR is supposed to be less complicated, less time 
consuming, cost-effective and superior to the conventional methods. It is also applicable for culture negative samples 
where strain identification is not possible by conventional approach. 
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1. INTRODUCTION 
  Based on surveillance and survey data, WHO estimates 
that 9.27 million new cases of TB occurred in 2007.Of these 
9.27 million new cases, an estimated 44% were new smear 
positive cases, 14.8% were HIV positive cases and 4.9% 
were MDR-TB (which includes 3.1% new cases and 19% 
previously treated cases). An estimated 1.32 million HIV-
negative people died from TB in 2007 and there were an 
additional 4,56,000 TB deaths among HIV positive people 
[ICD-10]. India is ranking top among 27 high MDR-TB   
burden countries. Incidence of MDR-TB in INDIA is   
reported to vary from 0.1%-5.4%.MDR-TB among all new 
TB cases are 2.8%, whereas 17% among the previously 
treated cases [1-5]. Moreover, the HIV/AIDS has produced a 
devastating effect on TB control worldwide [6]. Among the 
mycobacterial diseases (both pulmonary and extrapulmonary) 
M.tuberculosis complex has got the lion’s share. But the 
infection with Nontubercular Mycobacterium (NTM) or   
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Mycobacterium Other Than Tuberculosis (MOTT) is also 
increasing rapidly.  
  This MOTT complex can cause pulmonary infection as 
well as extrapulmonary lesions (Lymph node, skin & soft 
tissue, joint or systemic disseminated infection) in immuno-
compromised hosts. The majority of such infections are   
due to M. avium & M. intracellure (MAI).Other responsible 
pathogens are M.scrofulaceum, M.kansasii, M.fortuitum, 
M.ulcerans  etc. [7]. In 1959,Runyon classified NTM into 
four groups (I to IV) based on phenotypic characterization, 
particularly growth rate and pigmentation [8]. The treatment 
of diseases with M.tuberculosis complex and MOTT com-
plex are different because many of the first and second line 
of antitubercular drugs are ineffective against many members 
of the MOTT organisms. The most effective drugs against 
these organisms are macrolide or aminoglycoside antibiotics. 
The treatment protocol heavily depends on the species of 
mycobacterium isolated, site and severity of infection [9]. 
The report of drug sensitivity testing is not always reliable 
and the duration of the treatment is protracted. On other side 
Pyrazinamide is ineffective in M.bovis infection [10]. So, 
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particularly in case of patients not responding to conven-
tional therapy, relapse or in immunocompromised subjects. 
Moreover, an early diagnosis of species helps us to curtail 
huge burden of treatment with ineffective drugs and reduce 
patients’ morbidity and mortality [11]. 
  The conventional method of identification of species in-
volves culture on LJ slants and liquid medium followed by 
observing the rate of growth and pigment production (where 
applicable). Moreover, the growth of cultures was studied in 
different temperature gradient to identify the mycobacterial 
species. Biochemical tests like niacin production, nitrate 
reduction, semi quantitative and heat resistant catalase pro-
duction etc are also required [12]. 
  These are time consuming, complicated and laborious 
procedures whereas a multiplex PCR involving three ampli-
cons (165bp,365bp and 541bp fragments) can identify and 
differentiate between different species of mycobacterium 
[13, 14] and this method is also highly sensitive and specific 
[15]. 
2. MATERIALS & METHODS 
2.1. Specimen Collection 
  This cross sectional study was done with the Institutional 
Bioethical permission. Patients of all ages and both sexes 
recently diagnosed to be suffering from pulmonary or ex-
trapulmonary tuberculosis were randomly chosen from in 
and out patients’ departments of three tertiary care hospital 
in Kolkata, Eastern part of India. The diagnosis of tuberculo-
sis is based on the clinical examination, microscopy for 
AFB, manteaux test, Chest Skiagram, ESR, Cytological ex-
amination and ADA estimation of aspirated fluid . Sputum 
samples were collected from pulmonary tuberculosis pa-
tients. Body fluids (like CSF, pleural fluid, peritoneal fluid); 
blood, tissue or lymph node aspirates from patients with ex-
trapulmonary tuberculosis were collected aseptically using 
all precautions. Total numbers of samples were 165.The total 
span of the study was conducted from July 2006 to February 
2008. 
2.2. Specimen Processing 
  Sputum samples were liquefied and decontaminated   
using an equal volume of 4% NaOH, 2.9% Sodium citrate 
solution and N-Acetyl–L-Cysteine for 30 minutes incubation 
at room temperature. After decontamination, specimens were 
neutralized with sterile PBS (pH6.8). After centrifugation at 
3000Xg for 30 minutes, supernatant was discarded and 
sediment was suspended in sterile water.The body fluids 
were concentrated in usual methods. Tissue or lymph node 
aspirates decontaminated and concentrated for AFB smear, 
culture inoculation. PBMC layer were collected from the 
blood samples of the patients by histopaque density gradient 
method. All the samples were ready for isolating DNA.  
2.3. Demonstration of Acid Fast Bacilli Smears 
  Smears were prepared using the dissolved sediment from 
all specimens, stained by Ziehl-Neelson (ZN) method, and 
examined for presence of AFB with a light microscope. 
Smears recorded as positive if at least 1 to 9 AFB per 100 
high power fields were observed [16, 17]. 
2.4. Isolation of DNA and Multiplex PCR for Species 
Identification 
  After decontamination and concentration, sample was 
moistened with adjustable amount of TE buffer (pH 7.6). 
After scrapping the cytological material, it was dissolved 
thoroughly in TE buffer. Mycobacterial DNA was extracted 
from clinical specimens using a modification of the lysis 
method described by Sritharan and Barker (1991). The   
sediments were resuspended in 100 μl of TE-Triton X-100 
buffer (10 Mm Tris, 1 mM EDTA, and 1% Triton X-100, pH 
8) with 200 g/ml proteinase K, incubated at 56
oC for 3 
hours, and then incubated at 95
oC for 30 min. After each 
incubation, the specimens were placed on ice for 5 min. The 
protease-treated and heated specimens were next extracted 
with Phenol: Chloroform: Isoamyl Alcohol (25:24:1). The 
aqueous phases of the organic extractions were precipitated 
with ethanol overnight. The DNA was dissolved in 200 μl  
of TE buffer [18]. Reference strains of M. tuberculosis 
(H37RV), M. bovis, M. smegmatis, M. intracellulare and  
M. avium were obtained from Tuberculosis Research Centre 
(TRC), Chennai, India. Extraction of genomic DNA was 
done from reference strains cultured on LJ media by   
standard method. Multiplex PCR as earlier developed in   
our laboratory was done to amplify the following target   
sequences [19, 20]. 
 
Target Region  Primer Sequence 
5-CTA GGT CGG GAC GGT GAG GCC AGG- 3  65 KDa (hsp proteins) 
5-CAT TGC GAA GTG ATT CCT CCG GAT- 3 
5-AAG AGG AAG GAG AGA GGC- 3  dna J gene 
5-GTC GTT GAG GTT GAA CTC- 3 
5–GTG GGC ATG GTC GCA GAG AT–3  IS 6110 insertion element: 
5–CTC GAT GCC CTC ACG GTT CA–3 
 
  The PCR amplification was done in a Biometra Tper-
sonal DNA thermal cycler with an initial cycle of denatura-
tion (5min at 85°C), followed by 40 cycles each of 1 min  
at 94°C, 1 min at 55°C, and 2 min at 72°C, with a final   
 
 
extension of 10 min at 72°C and a post incubation of 30 min 
at 4°C. Each DNA amplification experiment included a posi-
tive control (Reference strains like: M. tuberculosis H37Rv 
DNA) and a negative control (distilled water). The amplified  
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DNA products were visualized under UV light and photo-
graphed after 2.5%agarose gel electrophoresis by ethidium 












Fig. (1). Multiplex PCR amplification of 165bp, 365bp and 541bp 
regions of the clinical specimens of M.tuberculosis and Nontuber-
cular mycobacterioses on 2.5% agarose gel. Lane 1: 100bp Molecu-
lar Marker; Lane 2-12: Clinical specimens (2,4,6: Atypical); 
(3,5,7,9,10:  M.Tuberculosis); (8: M.Bovis); (11,12: Inconclusive) 
(Lane 13: Positive Control; Lane 14: Negative Control. 
2.5. Culture by Inoculation in LJ Medium and Liquid 
Medium 
  All the samples (N=165) were included in the study The 
samples were inoculated on LJ media and liquid medium 
Middlebrook 7H9 with OADC supplement in our laboratory. 
The observations like rate of growth both at 30°C & 37°C, 
Colony character and pigment production (if any) in light 
and dark (on LJ slants) for colonies were noted: 
2.6. Biochemical Tests 
  Then biochemical tests like Niacin Production, Nitrate 
Production, Catalase production (semi quantitative & heat 
resistant), TWEEN-80 Hydrolysis, Growth in presence of 
Paranitrobenzoic acid (PNB) were done to differentiate 
among different strains of Mycobacterium tuberculosis com-
plex and NTM. To differentiate between Mycobacterium 
tuberculosis and Mycobacterium bovis, Growth on PZA con-
taining media, Sensitivity to TCH, Niacin production, Nitrate 
Reduction were performed [12, 21]. 
3. RESULTS AND DISCUSSION 
  In this study we found that out of 165 samples, 126 
(76.36%) were PCR positive whereas 95 (57.57%) were cul-
ture positive. The overall AFB positive samples was 85 
(15.5%) (Table 1). Out of total samples 136(82.42%) were 
sputum. Rest were pleural fluid(n=14),peritoneal fluid 
(n=02),CSF(n=06),Blood(n=04),Lymph node Aspirate(n=02) 
and tissues(n=01) (Table 2). Out of 126 PCR positive sam-
ples 102 (80.95%) showed all the three target amplifications 
and thus diagnosed as M.tuberculosis. Only 2(1.6%) cases 
were attributed to M.bovis which shows amplification only at 
165bp region .18 (14.28%) cases were nontuberculous my-
cobacteria and the rest 4 (3.10%) were inconclusive showing 
nonspecific amplifications.  
 
Table 1.  Comparisons of Tests Done in our Laboratory with PTB and EPTB Samples 
Experiments/Tests  Positive Result in Percentage  Distribution in Percentage 
AFB 85  (51.5%)  PTB:80(58.8) 
EPTB:5(12.6) 
Culture 95  (57.57)  PTB: 57 (64.77) 
EPTB: 7 (24.13) 
Polymerase Chain Reaction   126 (76.36)  PTB :110 (87.30) 
EPTB: 16 (55.17) 
 
Table 2.  Sample Distribution of PCR Positive Cases (N=165) of PTB & EPTB 
Type of Tuberculosis  Sample  Number of Cases 
Pulmonary (82.4%)  Sputum   136 
Pleural Fluid  14 
Peritoneal Fluid  02 
CSF 06 
Blood 04 
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  The atypical mycobacteria (NTM) were identified either 
by amplification of both 165 and 365 bp target sequences or 
only 165bp M. intracellulare amplicons were 20–40 bp 
shorter than that of M.tuberculosis or M. bovis (target region 
165 bp) due to small deletion. It can be used to differentiate 
this organism from the M .tuberculosis complex [19, 20]. 
  Out of 95 culture positive samples 72(75.78%) were   
Mycobacterium tuberculosis whereas 3 (3.16%) were 
M.bovis and 6 (6.32%) were MOTT or NTM. 14 (14.74%) 
strains remained inconclusive (Table 3). This study was   
in accordance with the study made by Schultz et al. [22], 
who demonstrated the isolations were 71% of M.tuberculosis 
and 34% of atypical mycobacterial strains from 191 archival 
specimens of tissues. In the study of Ergin et al. the respec-
tive isolations were 79.1%and 20.8% in 120 specimens   
[23]. 
Table 3.  Types  of  Mycobacteria Identified By PCR (N=126) 
and Culture (N=95) 
Species PCR  Positive  Culture  Positive 
M. tuberculosis  102(80.95%) 72(75.78%) 
M. bovis  02(1.6%) 03(3.16%) 
MOTT  18(14.28%) 06(6.32) 
Unidentified  04(3.1%) 14(14.74) 
Total  126 (100%)  95 (100 %) 
 
  Species identification by conventional cultural methods 
and biochemical tests are of limited value because of the 
comparatively low yield of the culture and long time to 
grow. Even the so-called rapid growers  may require 1-3 
weeks to grow. The differentiation of M.tuberculosis  and 
M.bovis is not always conclusive. Niacin production and 
PZA sensitivity tests lengthen the reporting time span. Pig-
ment production in light (photochromogens) and in both 
light and dark (scrotochromogens) are subjective observa-
tions that cannot be standardized To achieve good pigment 
production colonies should be young, actively metabolizing, 
isolated and well aerated. [24] Some members require pro-
longed exposure to light. Some others (like M. szulgi) need 
incubation at 35 ºC. In our study, we also observed the 
growth both at 30 ºC and at 37ºC.Moreover many important 
members of MOTT complex e.g. M.avium-intracellulare 
(MAI) and M.ulcerans etc. are nonchromogenic i.e. do not 
produce any pigment at all. Complicated biochemical tests 
like Niacin production, Nitrate reduction, Tween80 hydroly-
sis, Catalase etc. are required to differentiate them from 
M.tuberculosis complex as already mentioned. [12,25]. 
  In the current study, even with this time consuming labo-
rious effort the species identification by conventional meth-
ods is low. It was possible in 81 culture positive cases which 
are only 49.99% of total 165 cases. Schultz S et al. [22] also, 
in their study, found that only 41 out of 190 specimens 
(21.5%) were culture positive in which species identification 
could be made. On the other hand, species identification is 
much rapid and more accurate alternative where 122 cases 
out of 165(73.93%) could be categorized into different   
species. The overall isolation of M.tuberculosis  Complex 
(M.tuberculosis and M. bovis) is 63% [M.tuberculosis 
61.8%and M.bovis1.2%] in comparison to MOTT which is 
10.9%. 2.4% cases gave ambiguous results by showing non-
specific bands on PCR followed by gel electrophoresis. This 
may be due to contamination. Ergin et al. [23] in their study, 
evaluated in share of M.tuberculosis as 79.1% and MOTT as 
20.8% in 120 mycobacterial strains isolated from clinical 
specimens by PCR-RFLP. The result of our study is in ac-
cordance with the study made by Ergin et al. It is to be noted 
here that the failure in species identification by conventional 
methods is much higher (14 cases) which accounts for 8.48% 
of overall 165 cases.Over last decade, the rate of non-AIDS 
associated infection is also increasing and many of the newly 
identified NTM species have been identified using molecular 
biological tool (including DNA sequencing) rather than out-
dated phenotypic characterization. Thus PCR base studies 
along with some conventional tests are becoming indispen-
sable for proper identification of NTM organisms [12]. 
  The sensitivity and specificity of PCR depends on selec-
tion of the target sequence. Eisenarch et al. used primer de-
signed from IS6110 sequence to diagnose pulmonary tuber-
culosis [25]. Norle et al. demonstrated that IS 6110 based 
PCR assay is 91% sensitive & 100% specific in detecting 
Mycobacterium tuberculosis in sputum [26]. But Kent et al. 
detected 24 false positive cases out of 31 non tuberculosis 
cases. It was thought that mycobacterial species other than 
Mycobacterium tuberculosis might be responsible for this 
[27]. In this study we have included hsp 65 genes & dnaj 
gene along with IS6110 and performed a multiplex PCR, so 
that it does not only diagnose Mycobacterium tuberculosis 
with greater accuracy but also help to identify the species of 
mycobacterium, as already mentioned. But one point should 
be kept in mind. Due to widespread and ubiquitous presence 
of MOTT organisms in nature, they can colonize in different 
human organs without causing infection. Hence, mere isola-
tion of NTM organisms from clinical specimens is not tan-
tamount to infection by itself. Therefore the American Tho-
racic Society recommends diagnostic criteria for NTM dis-
eases to help physicians interpret laboratory results [12, 28]. 
4. LIMITATIONS OF THE STUDY 
  DNA sequencing, DNA micro array and line probe assay 
to identify the causative organisms are definitely more con-
clusive. If these procedures could be included, the study 
would get enriched. But belonging to third world country 
and having a huge burden of tuberculosis patients, these so-
phisticated tests could not be done as a routine practice. 
5. CONCLUSION 
  To differentiate between M.tuberculosis complex and 
nontuberculous mycobacteria, multiplex PCR is a very good 
tool. If it is used in conjunction with culture and biochemical 
tests; it is likely to give best results. Moreover, our in house 
developed multiplex PCR will be much more cost effective 
than other molecular biological assay.  
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